Marc T. Giles, President and Chief Executive Officer, commented: "We are pleased to report for the third quarter of fiscal 2008 that revenue, operating profit and earnings per share all increased as compared with the prior year. Revenue growth of $14.8 million, or 10.8 percent, as compared with the prior year, was led by the Sign Making and Specialty Graphics segment, through the strong performance of the Spandex business unit, with stronger aftermarket revenue and benefits from favorable foreign currency translation, and the incremental revenue provided by our acquisition of Data Technology early this fiscal year. Operating profit margin of 4.1 percent for the third quarter increased 1.1 percentage points, primarily as a result of lower selling, general and administrative expenses during the quarter as a percent of revenue compared with the fiscal quarter ended January 31, 2007. This improved operating performance resulted in a year-over-year increase in earnings per share for the third quarter of $0.03 per diluted share, after recording a non-cash pre-tax charge of $0.3 million, or $0.01 per diluted share, related to the write-off of deferred financing costs associated with the refinancing of the Company's credit facility."

Giles continued, "With regard to our exciting new product – the Solara ion™, we continue to expect to ship in volume during the first quarter of fiscal 2009. Also, pre-order volume has increased by approximately 45% to 125 orders from the amount reported in November 2007. "

About Gerber Scientific, Inc.
Gerber Scientific, Inc. (http://www.gerberscientific.com) is a leading international supplier of sophisticated automated manufacturing systems for the sign making and specialty graphics, apparel and flexible materials, ophthalmic lens processing, and print and packaging industries. Headquartered in South Windsor, Connecticut, the Company operates through four primary business units: Gerber Scientific Products, Spandex, Gerber Technology and Gerber Coburn.

Cautionary Note Concerning Factors That May Affect Future Results
This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements contained in this news release regarding the Company’s expected financial condition, results of operations, cash flows and product launches are forward-looking statements that involve risks and uncertainties. For information identifying other important economic, political, regulatory, legal, technological, competitive and other risks and uncertainties, readers are referred to the Company’s filings with the Securities and Exchange Commission, including but not limited to, the information included in Gerber Scientific’s Annual Report on Form 10-K for the fiscal year ended April 30, 2007 under the headings "Business," "Risk Factors" and "Management’s Discussion and Analysis of Financial Condition and Results of Operations – Cautionary Note Concerning Factors That May Influence Future Results," as well as information included in subsequently filed quarterly reports on Form 10-Q and current reports on Form 8-K, which outline certain important risks regarding the Company’s forward-looking statements. These risks include, but are not limited to, delays in the Company’s new product development and commercialization, intense competition in markets for each of the Company’s operating segments, rapid technological advances, availability and cost of raw materials, volatility in foreign currency exchange rates and fluctuations in interest rates. Actual future results or events may differ materially from those expressed or implied in the Company's forward-looking statements. The Company expressly disclaims any obligation to update any of these forward-looking statements.